Patients with low B7-H3 expression exhibited significantly better prognoses than those with high B7-H3 expression; thus, Sylwia proposed that B7-H3 warrants further investigation as a prognostic marker for AML (138). Here, CD276 is linked to acute myeloid leukemia.